Pharmacovigilance Outsourcing Market Size, Share and Forecast 2032

Pharmacovigilance Outsourcing Market

Pharmacovigilance Outsourcing Market - By Service Provider (Business Processing Outsourcing and Contract Research Organizations), By Service (Post-marketing Services (IT Solutions & Services and Knowledge Process Outsourcing Services) and Pre-marketing Services (Case-Processing Services, Clinical Pharmacovigilance Services, Medical Review, and Safety Data Management Services)), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 – 2032-

Category: Technology & Media Report Format : PDF Pages: 110 Report Code: ZMR-3881 Published Date: Oct-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 3.76 Billion USD 13.05 Billion 14.84% 2023

Pharmacovigilance Outsourcing Market

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
    • 2.2. Pharmacovigilance Outsourcing Market: Snapshot
  • Chapter 3. Global Pharmacovigilance Outsourcing Market– Industry Analysis
    • 3.1. Pharmacovigilance Outsourcing Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Need for reduction in costs of in-house pharmacovigilance system maintenance
      • 3.2.2. High requirement to reduce infrastructural costs
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Service Provider
      • 3.4.2. Market attractiveness analysis By Service
  • Chapter 4. Global Pharmacovigilance Outsourcing Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Pharmacovigilance Outsourcing Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Pharmacovigilance Outsourcing Market–Service Provider Analysis
    • 5.1. Global Pharmacovigilance Outsourcing Market overview: By Service Provider
      • 5.1.1. Global Pharmacovigilance Outsourcing Market share, By Service Provider,2019 and 2026
    • 5.2. Business Processing Outsourcing
      • 5.2.1. Global Pharmacovigilance Outsourcing Market by Business Processing Outsourcing, 2016–2026(USD Billion)
    • 5.3. Contract Research Organizations
      • 5.3.1. Global Pharmacovigilance Outsourcing Market by Contract Research Organizations, 2016–2026(USD Billion)
  • Chapter 6. Global Pharmacovigilance Outsourcing Market– Service Analysis
    • 6.1. Global Pharmacovigilance Outsourcing Market overview: By Service
      • 6.1.1. Global Pharmacovigilance Outsourcing Market share, By Service , 2019 and 2026
    • 6.2. Post-marketing Services
      • 6.2.1. Global Pharmacovigilance Outsourcing Market By Post-marketing Services, 2016–2026(USD Billion)
    • 6.3. Pre-marketing Services
      • 6.3.1. Global Pharmacovigilance Outsourcing Market By Pre-marketing Services, 2016–2026(USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Bioclinica
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Accenture
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Clintec
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. CliniRx Tangent Research
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Covance
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Cognizant
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Genpact
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Ergomed
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. IBM
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. HCL Technologies
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development
    • 7.11. iGATE
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Product Portfolio
      • 7.11.4. Business Strategy
      • 7.11.5. Recent Development
    • 7.12. ICON
      • 7.12.1. Overview
      • 7.12.2. Financials
      • 7.12.3. Product Portfolio
      • 7.12.4. Business Strategy
      • 7.12.5. Recent Development
    • 7.13. Infosys
      • 7.13.1. Overview
      • 7.13.2. Financials
      • 7.13.3. Product Portfolio
      • 7.13.4. Business Strategy
      • 7.13.5. Recent Development
    • 7.14. iMED Global
      • 7.14.1. Overview
      • 7.14.2. Financials
      • 7.14.3. Product Portfolio
      • 7.14.4. Business Strategy
      • 7.14.5. Recent Development
    • 7.15. IQVIA
      • 7.15.1. Overview
      • 7.15.2. Financials
      • 7.15.3. Product Portfolio
      • 7.15.4. Business Strategy
      • 7.15.5. Recent Development
    • 7.16. Medpace Huldings
      • 7.16.1. Overview
      • 7.16.2. Financials
      • 7.16.3. Product Portfolio
      • 7.16.4. Business Strategy
      • 7.16.5. Recent Development
    • 7.17. Oracle
      • 7.17.1. Overview
      • 7.17.2. Financials
      • 7.17.3. Product Portfolio
      • 7.17.4. Business Strategy
      • 7.17.5. Recent Development
    • 7.18. Novartis
      • 7.18.1. Overview
      • 7.18.2. Financials
      • 7.18.3. Product Portfolio
      • 7.18.4. Business Strategy
      • 7.18.5. Recent Development
    • 7.19. PRA Health Sciences
      • 7.19.1. Overview
      • 7.19.2. Financials
      • 7.19.3. Product Portfolio
      • 7.19.4. Business Strategy
      • 7.19.5. Recent Development
    • 7.20. Parexel
      • 7.20.1. Overview
      • 7.20.2. Financials
      • 7.20.3. Product Portfolio
      • 7.20.4. Business Strategy
      • 7.20.5. Recent Development
    • 7.21. Symogen
      • 7.21.1. Overview
      • 7.21.2. Financials
      • 7.21.3. Product Portfolio
      • 7.21.4. Business Strategy
      • 7.21.5. Recent Development
    • 7.22. SIRO Clinpharm
      • 7.22.1. Overview
      • 7.22.2. Financials
      • 7.22.3. Product Portfolio
      • 7.22.4. Business Strategy
      • 7.22.5. Recent Development
    • 7.23. Tata Consultancy Services (TCS)
      • 7.23.1. Overview
      • 7.23.2. Financials
      • 7.23.3. Product Portfolio
      • 7.23.4. Business Strategy
      • 7.23.5. Recent Development
    • 7.24. Tech Mahindra
      • 7.24.1. Overview
      • 7.24.2. Financials
      • 7.24.3. Product Portfolio
      • 7.24.4. Business Strategy
      • 7.24.5. Recent Development
    • 7.25. Syneos Health
      • 7.25.1. Overview
      • 7.25.2. Financials
      • 7.25.3. Product Portfolio
      • 7.25.4. Business Strategy
      • 7.25.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Pharmacovigilance Outsourcing Market attractiveness, By Service Provider
6. Global Pharmacovigilance Outsourcing Market attractiveness, By Service 
7. Global Pharmacovigilance Outsourcing Market share, By Service Provider, 2019 and 2026 (USD Billion)
8. Global Pharmacovigilance Outsourcing Market by Business Processing Outsourcing, 2016–2026(USD Billion)
9. Global Pharmacovigilance Outsourcing Market by Contract Research Organizations,2016–2026(USD Billion)
10. Global Pharmacovigilance Outsourcing Market Share by Service ,2019 and 2026 (USD Billion)
11. Global Pharmacovigilance Outsourcing Market by Post-marketing Services, 2016–2026(USD Billion)
12. Global Pharmacovigilance Outsourcing Market by Pre-marketing Services, 2016–2026(USD Billion)
13. Global Pharmacovigilance Outsourcing Market share, by Region, 2019 and 2026
14. North America Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
15. Europe Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
16. Asia Pacific Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
17. Latin America Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
18. The Middle East and Africa Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)


Table Of Tables

List of Tables

1. Global Pharmacovigilance Outsourcing Market: snapshot
2. Drivers of the Pharmacovigilance Outsourcing Market: impact analysis
3. North America Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
4. North America Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
5. The U.S. Pharmacovigilance Outsourcing Market revenue, By Service Provider, 2016–2026(USD Billion)
6. The U.S. Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
7. Rest of North America Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
8. Rest of North America Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
9. Europe Pharmacovigilance Outsourcing Market revenue, By Service Provider, 2016–2026(USD Billion)
10. Europe Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
11. UK Pharmacovigilance Outsourcing Market revenue, By Service Provider ,2016–2026(USD Billion)
12. UK Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
13. France Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
14. France Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
15. Germany Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
16. Germany Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
17. Rest of Europe Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
18. Rest of Europe Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
19. Asia Pacific Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
20. Asia Pacific Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
21. China Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
22. China Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
23. Japan Pharmacovigilance Outsourcing Market revenue, By Service Provider, 2016–2026(USD Billion)
24. Japan Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
25. India Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
26. India Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
27. Rest of Asia Pacific Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
28. Rest of Asia Pacific Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
29. Latin America Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
30. Latin America Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
31. Brazil Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
32. Brazil Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
33. Rest of Latin America Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
34. Rest of Latin America Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
35. The Middle East and Africa Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
36. The Middle East and Africa Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
37. Saudi Arabia Pharmacovigilance Outsourcing Market revenue, By Service Provider, 2016–2026(USD Billion)
38. Saudi Arabia Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
39. South Africa Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
40. South Africa Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
41. Rest of the Middle East & Africa Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
42. Rest of the Middle East & Africa Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
 
 

Methodology

FrequentlyAsked Questions

The key growth drivers that will leverage the market growth include reduction in costs of in-house pharmacovigilance system maintenance & saving infrastructural costs.

The CAGR of the industry is expected to be nearly over 15.6% during the forecast timespan.

North American region will contribute remarkably towards the global market share over the estimated timeline.

The key market participants include Genpact, Bioclinica, Tata Consultancy Services (TCS), Accenture, PRA Health Sciences, Clintec, SIRO Clinpharm, CliniRx Tangent Research, Covance, Infosys, Tech Mahindra, Cognizant, Ergomed, IBM, HCL Technologies, iGATE, ICON, iMED Global, Medpace Holdings, IQVIA, Oracle, Novartis, Parexel, Symogen, and Syneos Health.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed